|
Volumn 2, Issue 1, 2016, Pages 54-55
|
PD-L1 Expression as a predictive biomarker: Is absence of proof the same as proof of absence?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROGRAMMED DEATH 1 LIGAND 1;
TUMOR MARKER;
CHEMISTRY;
FEMALE;
FLUORESCENT ANTIBODY TECHNIQUE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LUNG TUMOR;
MALE;
NON SMALL CELL LUNG CANCER;
STANDARDS;
ANTIGENS, CD274;
BIOMARKERS, TUMOR;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
FLUORESCENT ANTIBODY TECHNIQUE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LUNG NEOPLASMS;
MALE;
|
EID: 84964932463
PISSN: 23742437
EISSN: 23742445
Source Type: Journal
DOI: 10.1001/jamaoncol.2015.3782 Document Type: Note |
Times cited : (44)
|
References (6)
|